Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
369.82
+7.08 (1.95%)
Apr 29, 2026, 10:45 AM EDT - Market open
Elevance Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 5,243 | 5,662 | 5,980 | 5,987 | 5,894 | 6,158 | Upgrade
|
| Depreciation & Amortization | 724 | 743 | 659 | 1,060 | 1,076 | 817 | Upgrade
|
| Other Amortization | 803 | 803 | 734 | 685 | 599 | 485 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -201 | - | - | - | Upgrade
|
| Stock-Based Compensation | 250 | 276 | 191 | 289 | 264 | 255 | Upgrade
|
| Change in Accounts Receivable | -526 | -2,526 | -683 | -1,762 | -2,510 | -2,138 | Upgrade
|
| Change in Accounts Payable | 1,214 | -720 | -272 | 1,640 | 824 | 719 | Upgrade
|
| Change in Unearned Revenue | 119 | -15 | -113 | 290 | -42 | -113 | Upgrade
|
| Change in Income Taxes | -10 | -297 | 404 | -103 | -338 | 140 | Upgrade
|
| Change in Insurance Reserves / Liabilities | 1,218 | 228 | -1,840 | 147 | 2,411 | 2,523 | Upgrade
|
| Change in Other Net Operating Assets | -847 | 53 | 785 | -747 | 78 | -8 | Upgrade
|
| Other Operating Activities | -118 | 373 | 62 | 96 | 429 | 15 | Upgrade
|
| Operating Cash Flow | 7,605 | 4,290 | 5,808 | 8,061 | 8,399 | 8,364 | Upgrade
|
| Operating Cash Flow Growth | 56.90% | -26.14% | -27.95% | -4.02% | 0.42% | -21.74% | Upgrade
|
| Capital Expenditures | -1,155 | -1,116 | -1,256 | -1,296 | -1,152 | -1,087 | Upgrade
|
| Cash Acquisitions | 89 | 88 | -4,809 | -1,552 | -649 | -3,476 | Upgrade
|
| Investment in Securities | -1,630 | 69 | 586 | -2,700 | -2,338 | -4,056 | Upgrade
|
| Other Investing Activities | -393 | -385 | -51 | -24 | -421 | -1,019 | Upgrade
|
| Investing Cash Flow | -3,089 | -1,344 | -5,167 | -5,572 | -4,560 | -9,638 | Upgrade
|
| Short-Term Debt Issued | - | 3,203 | 275 | 339 | 2,600 | 2,331 | Upgrade
|
| Long-Term Debt Issued | - | 2,991 | 7,710 | 2,574 | 3,071 | 3,462 | Upgrade
|
| Total Debt Issued | 6,395 | 6,194 | 7,985 | 2,913 | 5,671 | 5,793 | Upgrade
|
| Total Debt Repaid | -4,554 | -3,867 | -2,498 | -2,251 | -3,574 | -2,494 | Upgrade
|
| Net Debt Issued (Repaid) | 1,841 | 2,327 | 5,487 | 662 | 2,097 | 3,299 | Upgrade
|
| Issuance of Common Stock | 93 | 79 | 221 | 152 | 182 | 203 | Upgrade
|
| Repurchases of Common Stock | -2,792 | -2,637 | -3,009 | -2,775 | -2,409 | -2,002 | Upgrade
|
| Common Dividends Paid | -1,519 | -1,529 | -1,508 | -1,395 | -1,229 | -1,104 | Upgrade
|
| Other Financing Activities | 33 | 22 | 2 | 7 | 41 | 27 | Upgrade
|
| Financing Cash Flow | -2,344 | -1,738 | 1,193 | -3,349 | -1,318 | 423 | Upgrade
|
| Foreign Exchange Rate Adjustments | -15 | -5 | -6 | -1 | -14 | -10 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -66 | - | - | - | Upgrade
|
| Net Cash Flow | 2,157 | 1,203 | 1,762 | -861 | 2,507 | -861 | Upgrade
|
| Free Cash Flow | 6,450 | 3,174 | 4,552 | 6,765 | 7,247 | 7,277 | Upgrade
|
| Free Cash Flow Growth | 75.56% | -30.27% | -32.71% | -6.65% | -0.41% | -24.72% | Upgrade
|
| Free Cash Flow Margin | 3.22% | 1.59% | 2.57% | 3.95% | 4.63% | 5.25% | Upgrade
|
| Free Cash Flow Per Share | 28.94 | 14.13 | 19.55 | 28.50 | 29.85 | 29.48 | Upgrade
|
| Cash Interest Paid | 1,410 | 1,410 | 1,239 | 1,032 | 878 | 822 | Upgrade
|
| Cash Income Tax Paid | 315 | 315 | - | - | 1,594 | 1,299 | Upgrade
|
| Levered Free Cash Flow | 4,299 | 3,400 | 7,262 | 3,005 | 8,425 | 3,614 | Upgrade
|
| Unlevered Free Cash Flow | 5,184 | 4,277 | 8,002 | 3,649 | 8,960 | 4,115 | Upgrade
|
| Change in Working Capital | 1,168 | -3,277 | -1,719 | -535 | 423 | 1,123 | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.